We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byAlexys Dallis
Modified over 2 years ago
© 2004 Cardinal Health. All rights reserved. PET/CT: Improved Confidence in Imaging ?
© 2004 Cardinal Health. All rights reserved. Why PET/CT Improved diagnostic accuracy over PET or CT alone More Accurate Disease Staging More Accurate Surgical Planning More Accurate Guided Biopsy More Accurate Radiation Therapy Planning IMPROVED DIAGNOSTIC CONFIDENCE (for improved patient management)
© 2004 Cardinal Health. All rights reserved. History of Radiology and Cancer Form = Anatomy Anatomy continues to be the cornerstone of cancer imaging for diagnosis, staging and follow up. Form has served us very well in X-Ray, US, CT, and MR “50 Years of Imaging Form” MR CT
© 2004 Cardinal Health. All rights reserved. “Form” Strengths and Limitations Strengths …butDiagnostic Questions Remain Clear delineation of formWhat is normal? Performance is less post operative due to distortion of normal anatomy Accurate detection andWhat is the mass? (fat? water? air?) localization of masses Accurate detection of lymph What is within the lymph nodes? nodes (present or absent) (benign or malignant?) Some small lesion What is the cause? identification Have small tumor foci been over- looked (especially if surrounded by normal tissues)?
© 2004 Cardinal Health. All rights reserved. “Form” Strengths and Limitations Treatment Planning Questions Also Remain What will be the response to a particular therapy? What sort of tumor biology is present? Has there been a response (especially cytostatic) that I’m not seeing yet because it’s too soon for the “form” to reflect changes? PET (and PET/CT) address many of the limitations of anatomic imaging alone
© 2004 Cardinal Health. All rights reserved. “Function” Imaging – FDG-PET FDG-PET Strengths …but High sensitivity for detection of abnormal cell metabolism Real-time measurements of changes in disease state (and hence effectiveness of therapy) Powerful rotating display formats to aid in accurate interpretations based on human motion-oriented vision
© 2004 Cardinal Health. All rights reserved. “Function” Imaging – FDG-PET …but Questions Remain Where is the tracer uptake? Where should we biopsy? Where should we resect? Is the tracer uptake in tumor or non- malignant tissues (e.g. infection)?
© 2004 Cardinal Health. All rights reserved. PET shows modest basilar lung FDG uptake? CT shows infiltrates at both lung bases. Clearly abnormal. Tough Questions What is it?
© 2004 Cardinal Health. All rights reserved. What is PET/CT? Where Form meets Function A view into the body that allows us to see what it is happening and where. Hybrid Imaging Device/Modality Diagnostic CT scanner (high quality images of anatomy) PET scanner (high quality images of function) Computer and software to fuse/display images No patient motion between studies (or very little)
© 2004 Cardinal Health. All rights reserved. What is PET/CT? Where Form meets Function The best of detection and localization Better than PET or CT alone lung cancer normal heart
© 2004 Cardinal Health. All rights reserved. More Accurate Staging PET/CT Sensitivity to hyper-metabolism in normal-sized nodes on CT. Accurate spatial localization of abnormalities detected on PET, but difficult to localize.
© 2004 Cardinal Health. All rights reserved. More Accurate Staging No enlarged lymph nodes seen in the apex of the thorax on CT. Focal area of increased radionuclide uptake found on PET. Exact location remained unclear. PET/CT fused image matched hyper- metabolism to a normal-sized lymph node. Metastatic disease confirmed via histology. Chemotherapy initiated. Lardinois, et. al., NEJM 2003, 348: mm lymph node met NSCLC
© 2004 Cardinal Health. All rights reserved. More Accurate Staging Breast cancer patient Malignant cell activity localized in a normal sized axillary lymph node. Disease overlooked on CT alone. Hao Vuong, MD, Baptist Hospital of Miami
© 2004 Cardinal Health. All rights reserved. More Accurate Surgical Planning Colorectal cancer patient PET/CT demonstrates a solitary met in the liver Upstages patient to Stage IV Despite Stage IV, PET/CT indicates there is still a possibility of surgical cure, based on the localization of primary and metastatic activity. Hao Vuong, MD, Baptist Hospital of Miami
© 2004 Cardinal Health. All rights reserved. More Accurate Guided Biopsy CT shows LUL mass consistent with Lung Cancer and no nodal metastases PET shows right paratracheal uptake suggesting nodal metastasis PET/CT shows metastasis to normal sized right paratracheal node Proven by biopsy.
© 2004 Cardinal Health. All rights reserved. More Accurate Guided Biopsy Head and Neck cancer patient PET/CT identifies a nasopharyngeal squamous cell carcinoma Confirms increased metabolic activity is localized in a bilateral lymph node. Patient therapy plan is changed from limited-field radiation treatment to a combined radiation/chemotherapeutic approach.
© 2004 Cardinal Health. All rights reserved. More Accurate RT Planning PET/CT is performed on a radiation therapy table to ensure consistent patient positioning. Fiducial markers are evident in the images. PET/CT images can be moved directly into radiation therapy planning workstations for seamless integreation of metabolic, anatomic, and irradiation planning information.
© 2004 Cardinal Health. All rights reserved. More Accurate RT Planning History 63 YOF, nasopharyngeal cancer 5 yrs prior Presents with progressive dysphagia and neck pain Panendoscopy negative, MRI unrevealing PET/CT Findings FDG accumulation in the posterior aspect of the larynx (SUV= 15.8) – not shown here Small focus with mild FDG uptake (SUV = 1.2) corresponding to a small lymph node in the left neck. Impact to Patient Management Deep biopsies confirmed squamous cell carcinoma, likely the development of a second primary head and neck cancer. Mild FDG uptake in the small node is likely to be metastatic. Radiation therapy was selected as the primary treatment. The PET/CT images were used in planning the radiation therapy. SUV = 1.2
© 2004 Cardinal Health. All rights reserved. Improved Confidence CT is clearly abnormal PET is mildly abnormal When combined: Worrisome for brochioloalveolar carcinoma Confirmed by biopsy Bronchioloalveolar Carcinoma
© 2004 Cardinal Health. All rights reserved. Characterization and Localization CT shows precise lesion size, shape and location PET shows increased FDG uptake Non-Small-Cell Lung Cancer
© 2004 Cardinal Health. All rights reserved. Confirmation of Benign Nodule CT shows pulmonary nodule which is large enough to image with PET PET shows no increased tracer uptake No disease present
© 2004 Cardinal Health. All rights reserved. Better than PET or CT alone Diagnostic Accuracy with Respect to Tumor Stage (40 Pts) Non-Small-Cell Lung Cancer Classification Correct but Imaging MethodCorrect EquivocalIncorrect CT alone58%20% 22% PET alone40%40% 20% Visual correlation of65%12% 22% PET and CT Integrated PET-CT88%10% 2% Lardinois, et. al., NEJM 2003, 348:
© 2004 Cardinal Health. All rights reserved. Better than PET or CT alone Diagnostic Accuracy with Respect to Node Stage (37 Pts) Non-Small-Cell Lung Cancer Classification Correct but Imaging MethodCorrect EquivocalIncorrect CT alone59%5% 35% PET alone49%38% 14% Visual correlation of59%11% 30% PET and CT Integrated PET-CT81%3% 16% Lardinois, et. al., NEJM 2003, 348:
© 2004 Cardinal Health. All rights reserved. Improved Certainty What is Tumor?What is Not? History of Melanoma
© 2004 Cardinal Health. All rights reserved. Normal Tissues with FDG Uptake Not everything using glucose is tumor. Anatomy can be helpful in making this separation. Example: Normal Head and Neck areas of increased FDG metabolism (Minimize by NOT talking during uptake nor swallowing) Tonsils Submandibular and Parotid Glands Cricoarytenoid muscles
© 2004 Cardinal Health. All rights reserved. Parotids, Soft Palate, Spinal Cord Normal FDG-PET Map
© 2004 Cardinal Health. All rights reserved. PET/CT: Faster Scan Time Much faster total scan time than PET alone (approx 20 minutes) CT provides 30 second transmission scans for the PET study vs 20 minute transmission scans with PET only devices 40-50% increased scan volume capacity Improved cost-effectiveness with improved productivity 20 min emission20 min transmission 20 min emission 20 sec transmission PET Only PET/CT 40 min 20 min
© 2004 Cardinal Health. All rights reserved. Patient preparation Fasting for four hours Patient changed into gown and pants All metallic objects are removed Check glucose levels < 200 mg/dl 2 bottles of Readi-CAT (Barium sulphate 1.3 %) oral CT contrast prior to injection of 18 F-FDG
© 2004 Cardinal Health. All rights reserved. Patient Preparation PET Scan Preparation Fasting for 4 hours Patient changed into gown and pants All metallic objects are removed Check glucose levels (< 200 mg/dl).22 mCi/kg FDG for whole body imaging (injected dose varies by scanner) 2D or 3D imaging of whole body(3D imaging of brain) CT Scan Preparation Patient is positioned head first and supine on the table Scanning begins from meatus of ear to mid thigh Shallow breathing during the CT Currently, non contrast CT is best choice for transmission images as arterial contrast can cause artifacts
© 2004 Cardinal Health. All rights reserved. Scan Protocols PET Scan Protocol 3-5 minute emission per FOV for Whole Body imaging 3 minute emission per FOV for Melanoma imaging (more FOVs) minute emission for 3D brain imaging CT Scan Protocol Helical High Speed Pitch mm/rotation 5 mm slices 140 kV & 80mA—varies 50 cm DFOV 512 x 512 matrix
© 2004 Cardinal Health. All rights reserved. PET/CT (Fusion) Workstations Fusion occurs on the PET/CT scanner workstation Hi-Res CT images are minimized to 128x128 matrix Images can be displayed in any plane or slice MIP (3D PET images) and CT Scout views are provided
© 2004 Cardinal Health. All rights reserved. Where Form meets Function PET is Very Accurate. PET/CT is even more Accurate. Disease Staging Surgical Planning Guided Biopsy Radiation Therapy Planning PET/CT Better than PET or CT alone Editor: Richard L. Wahl, M.D. Division of Nuclear Medicine Department of Radiology Johns Hopkins Medical Institutes Other Contributors: Hao Vuong Baptist Hospital of Miami Jack Ziffer Baptist Hospital of Miami Homer Macapinlac MD Anderson Cancer Center
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.
Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management J Nucl Med 2006; 47:616–624 報告者 : 蘇惠怡.
CLINICAL USE OF SPECT-CT IN BREAST & PROSTATE CANCERS Emerita A. Barrenechea, MD Department of Nuclear Medicine St Luke’s Medical Center St Luke’s Medical.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
George Segall, M.D. Stanford University PET/CT in Oncology.
Update on 18 F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/ Computed Tomography Imaging of Squamous Head and Neck.
Brain Scan Imaging MRI, CAT, PET Imaging Interpreting Functions of the Brain through Imaging – Activity Case Study – Professional Sports and Head Trauma.
IMAGING OF INCIDENTAL ADRENAL LESIONS: PRINCIPLES, TECHNIQUES AND ALGORITHMS Giles W.L. Boland Massachusetts General Hospital Harvard Medical School.
Dual-time point 18F-FDG PET/CT scan: is it always working? Dr. Hussein R. S. Farghaly Prince Sultan Military Medical City.
PET in Colorectal Cancer. Indications for FDG PET Rising marker, (-) CT/MRI Nonspecific findings on CT/MRI, recurrence or post treatment changes? Known.
Application of Positron Emission Tomography ( PET ) in Colorectal Cancer Dr Chan Wai Keung Department of Surgery Ruttonjee and Tang Shiu Kin Hospitals.
Positron Emission Tomography (PET). History 1975 the first commercial PET scanner was introduced 70s and 80s PET was mainly used for research 1990s being.
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
Functional Imaging with PET for Sarcoma Rodney Hicks, MD, FRACP Director, Centre for Molecular Imaging Guy Toner, MD, FRACP Director, Medical Oncology.
Khuram Ameen. Good for Proximal Lesions Yield low for peripheral nodules 10-20%
NeoTect Tc99m Depreotide Injection. NeoTect Approved by the FDA - August 3, 1999 Used in Imaging Pulmonary Masses Normal activity in high concentrations.
AN INTRODUCTION TO PET-CT SCANNING Ray Murphy Chair – MCCN Partnership Group.
Differential diagnosis of head and neck swellings DR.ALI AL-HIYALI BDS,MSC OMFS UNIVERSITY OF GLASGOW(UK) BDS
Supraclavicular metastasis from urothelial bladder carcinoma: A case report S. Farmahan, T. Mirza, P. Ameerally Oral Maxillofacial Department, Northampton.
Nuclear Medicine and PET rev this is now slide 1do not print it to pdf things to do (check off when complete): add revision date to cover page.
The Value of PET Scan in the Routine Follow-up of Patients with Squamous Cell Carcinoma of the Head and Neck Yasir Rudha, MD; Amr Aref, MD; Paul Chuba,
Radiology Research at BUMC Jorge Soto, MD Vice Chair Research, Radiology Associate Professor, Radiology 12/19/07.
Determining the Nature of a Breast Abnormality It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
A prospective study of PET/CT in initial staging of small-cell lung cancer : comparison with CT, bone scintigraphy and bone marrow analysis B. M. Fischer1,
Figure 1: a 32-year-old woman presented with RT breast mass, MRI showed false positive diagnosis of cancer. Dynamic contrast enhanced MRI, axial subtraction.
MedPix Medical Image Database COW - Case of the Week Case Contributor: Jason Blitz Affiliation: Uniformed Services University.
Follow up in Chest Tumors : Value of integrated PET/CT By : Dr. Heba Nabil, MSc Radiology Specialist at Nasser Institute For Research and Treatment.
STAGING OF BRONCHOGENIC CA NSCLC STAGING TNM CLASSFICATION Adenocarcinoma Squamous cell carcinoma Large cell carcinoma T – Primary tumor N – Regional.
The Thyroid Incidentaloma Dimyati Achmad Department of Surgery Faculty of Medicine Padjadjaran University/ Hasan Sadikin Hospital Bandung Indonesia.
Radiologic Imaging Defines the local extent of a tumor Can be used to stage malignant disease Aids in the diagnosis Monitoring tumor changes after treatment.
Objective Comparison of direct real-time endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA), PET, CT for detection of mediastinal.
11th Biennial Meeting of the International Gynecologic Cancer Society 11th Biennial Meeting of the International Gynecologic Cancer Society Semih Gorgulu,
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
Metastatic involvement (M) M0 - No metastases M1 - Metastases present.
Thorax / Lung Basic Science Conference 12/21/2005 J.R. Nitzkorski.
PHYSICS IN NUCLEAR MEDICINE: QUANTITAITVE SPECT AND CLINICAL APPLICATIONS Kathy Willowson Department of Nuclear Medicine, Royal North Shore Hospital University.
18 F-FET PET Compared with 18 F- FDG PET and CT in Patients with Head and Neck Cancer Present by Intern 羅穎駿 Journal of Nuclear Medicine Vol. 47 No
Date of download: 6/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Diagnostic Accuracy of Colorectal Cancer Staging.
© 2007 Cardinal Health. All rights reserved. Marketing PET in Radiation Treatment Planning PET Marketing Forum – Accelerating Practice Growth May 23, 2007.
Innovation is in our genes. 1 Siemens Medical Solutions Molecular Imaging What are PET basics?
Characteristic Dynamic Enhancement Pattern of MR imaging for Malignant Thyroid Tumor XIX Symposium Neuroradiologicum Division of Head & Neck radiology.
핵의학과 PK 18 조 68 번 주리히 Case presentation 2 Disease review 3 Journal review.
FDG-PET/CT PATTERNS AND PREVALENCE OF PERITONEAL SPREAD IN OVARIAN CANCER Srour SF 1, Bar-Shalom R 2 Srour SF 1, Bar-Shalom R 2 1 Department of Diagnostic.
ACRIN 6685 Overview ACRIN 6685 A Multi-center Trial of FDG-PET/CT Staging of Head and Neck Cancer and its Impact on the N0 Neck Surgical Treatment in Head.
MEDICAL IMAGING. RADIOLOGY Radiology is a medical specialty that uses imaging techniques to both diagnose and treat disease visualized within the human.
Preoperative staging of hilar cholangiocarcinoma by dual-modality PET/CT. DR SIKANDAR YASHODA HOSPITALS HYDERABAD.
Chapter 28 Lung Cancer. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Objectives Describe the epidemiology of.
Clinical Utility of Combidex in Various Cancers Jelle O. Barentsz, MD Professor of Radiology University Medical Center Nijmegen, Netherlands.
Surgical principle of Management of Tumors M.A.Kubtan, MD – FRCS 1 st Lecture 1M.A.Kubtan.
PET Applications in Oncology الدكتور قصي المقبل أستاذ مشارك- قسم الأشعة والطب النووي كلية الطب-جامعة العلوم والتكنولوجيا الأردنية.
© 2017 SlidePlayer.com Inc. All rights reserved.